Relationship of serum interleukin-7 concentration and the coagulation state in children with nephrotic syndrome

Pediatrics International

Volumn 47, Issue 4, 2005, Pages 424-429

  Wasilewska, Anna ^a   Zoch Zwierz, Walentyna M ^a   Tomaszewska, Barbara ^a   Zelazowska, Beata ^b  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b Department of Paediatric Laboratory Diagnostics ^*  (Poland)

Author keywords

Children; Hemostasis; Interleukin 7; Nephrotic syndrome; Platelets

Indexed keywords

ANTITHROMBIN III; CHOLESTEROL; FIBRINOGEN; INTERLEUKIN 7; PREDNISONE; SERUM ALBUMIN;

ADOLESCENT; ARTICLE; BLOOD CLOTTING; CHILD; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBRINOGEN BLOOD LEVEL; HUMAN; HYPERCOAGULABILITY; MALE; NEPHROTIC SYNDROME; PRIORITY JOURNAL; PROTEIN URINE LEVEL; PROTEINURIA; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOCYTOSIS;

CHILD; FEMALE; HEMOSTASIS; HUMANS; INTERLEUKIN-7; MALE; NEPHROTIC SYNDROME; PLATELET AGGREGATION; PLATELET COUNT; SERUM ALBUMIN;

EID: 23844498279     PISSN: 13288067     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1442-200x.2005.02078.x     Document Type: Article

References (28)

1. Anand NK, Chand G, Talib VH, Chellani H, Pande J. Hemostatic profile in nephrotic syndrome. Indian Pediatr. 1996; 33: 1005-12.
2. Schlegel N. Thromboembolic risks and complications in nephrotic syndrome. Semin. Thromb. Hemost. 1997; 23: 271-80.
3. Tkaczyk M, Owczarek D, Puczko-Nogal B et al. Activation of coagulation cascade in children during an idiopathic nephrotic syndrome. Pol. Merkuriusz Lek. 2000; 8: 226-7.
4. Pathansali R, Smith N, Bath P. Altered megakaryocyte-platelet haemostatic axis in hypercholesterolemia. Platelets 2001; 12: 292-7.
5. Zdrojewski Z, Raszeja-Specht A, Kustosz J, Skibowska A, Rutkowski B. Evaluation of factors influencing platelet aggregation in patients with chronic glomerulonephritis (CGN). Przegl. Lek. 1996; 53: 434-8.
6. Soslau G, Morgan DA, Jaffe JS, Brodsky I, Wang Y. Cytokine mRNA expression in human platelets and megacariocytic cell line and cytokine modulation of platelet function. Cytokine 1997; 9: 405-11.
7. Wasilewska AM, Zoch-Zwierz WM, Tomaszewska B, Biernacka A. Platelet-derived growth factor and platelet profiles in childhood nephrotic syndrome. Pediatr. Nephrol. 2005; 20: 36-41.
8. Shanwell A, Falker C, Gulliksson H. Storage of platelets in additive solutions: the effects of magnesium and potassium on the release of RANTES, beta-thromboglobulin, platelet factor 4 and interleukin-7, during storage. Vax Sang 2003; 85: 206-12.
9. Damas JK, Wahre T, Yndestad A et al. Interleukin-7-mediated inflammation in unstable angina. Possible role of chemokines and platelets. Circulation 2003; 107: 2670-6.
10. Akashi K, Kondo M, Weissman IL. Role of interleukin-7 in T-cell development from hematopoietic stem cells. Immunol. Rev. 1998; 165: 13-28.
11. Namen AE, Williams DE, Goodwin RG. Interleukin-7: a new hematopoietic growth factor. Prog. Clin. Biol. Res. 1990; 338: 65-73.
12. Welch PA, Namen AE, Goodwin RG, Armitage R, Cooper MD. Human IL-7: a novel T cell growth factor. J. Immunol. 1989; 143: 3562-7.
13. Fry TJ, Connick E, Falloon J et al. A potential role for interleukin-7 in T-cell homeostasis. Blood 2001; 9: 2983-90.
14. Li L, Masucci MG, Levisky V. Effect of interleukin-7 on the in vitro development and maturation of monocyte-derived human dendritic cells. Scand. J. Immunol. 2000; 51: 361-71.
15. Johnson JG. 1996 International Cell Biology Society. J. Cell Biol. 1996.
16. Sin J, Kim J, Patchuk C, Wiener D. Interleukin 7 can enhance antigen-specific cytotoxic-t-lymphocyte and/or th2-type immune responses in vivo. Clin. Diagn. Lab. Immunol. 2000; 9: 751-8.
17. Schluns KS, Kieper WC, Jameson SC, Lefrancois L. Interleukin-7 mediates the homeostasis of naive and memory CD8 T cells in vivo. Nature Immunol. 2000; 1: 426-32.
18. Harada S, Yamamura M, Okamoto H et al. Production of interleukin-7 and interleukin-15 by fibroblast-like synoviocytes from patients with reumatoid arthritis. Arthritis Rheum. 1999; 42: 1508-16.
19. Watanabe M, Ueno Y, Yajima T et al. Interleukin 7 transgenic mice develop chronic colitis with decreased interleukin-7 protein accumulation in the colonic mucosa. J. Exp. Med. 1998; 187: 389-402.
20. Wandelbo O, Glenjen N, Bruserud O. Interleukin-7 (IL-7) in patients receiving intensive chemotherapy for acute myelogenous leukemia: studies of systemic IL-7 levels and IL-7 responsiveness of circulating T lymphocytes. J. Interferon Cytokine Res. 2002; 22: 1057-65.
21. Abdullah R. Hemostatic abnormalities in nephrotic syndrome. Vet. Clin. North Am. Small Anim. Pract. 1988; 18: 175-83.
22. Zdrojewski Z, Raszeja-Specht A, Skibowska A, Owczarzak A, Rutkowski A. Hypercoagulation in patients with nephrotic syndrome. Pol. Merkuriusz Lek. 1997; 2: 201-4.
23. Grimbert P, Audard V, Remy P, Lang P, Sahali D. Recent approaches to the pathogenesis of minimal-change nephrotic syndrome. Nephrol. Dial. Transplant. 2003; 18: 245-8.
24. van Roon JA, Glaudemans KA, Bijlsma JW, Lafeber FP. Interleukin-7 stimulates tumour necrosis factor alpha and TH1 cytokine production in joints of patients with rheumatoid arthritis. Ann. Rheum. Dis. 2003; 62: 113-19.
25. Neuhaus TJ, Shah V, Callard RE et al. T-lymphocyte activation in steroid-sensitive nephrotic syndrome in childhood. Nephrol. Dial. Transplant. 1995; 10: 1348-52.
26. Sirolli V, Ballone E, Garofalo D et al. Platelet activation markers in patients with nephrotic syndrome. A comparative study of different platelet function tests. Nephron 2002; 91: 424-30.
27. Turi S, Bereczki CS, Torday CS, Havass Z. Laser aggregometer studies, ATP release and thromboxane B2 release and cAMP concentration of the platelets in nephrotic syndrome. Prostaglandins Leukot. Essent. Fatty Acids 1994; 51: 69-73.
28. Alderson MR, Tough TW, Ziegler SF, Grabstein KH. Interleukin-7 induces cytokine secretion and tumoricidal activity by human peripheral blood monocytes. J. Exp. Med. 1991; 173: 923-30.